Nanomedicine-Nanotechnology Biology and Medicine

Papers
(The H4-Index of Nanomedicine-Nanotechnology Biology and Medicine is 24. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Robust aptamer-targeted CRISPR/Cas9 delivery using mesenchymal stem cell membrane –liposome hybrid: BIRC5 gene knockout against melanoma73
Corrigendum to “A light-up “G-quadruplex nanostring” for label-free and selective detection of miRNA via duplex-specific nuclease mediated tandem rolling circle amplification” [Nanomed.: Nanotechnol. 71
Delivery of gene editing therapeutics65
Comparative examination of the chemistry and biology of AI-driven gold NPs in Theranostics: New insights into biosensing, bioimaging, genomics, diagnostics, and therapy56
Therapeutic effects of cationic liposomes on lupus-prone MRL/lpr mice are mediated via inhibition of TLR4-triggered B-cell activation50
Dye labeling for optical imaging biases drug carriers' biodistribution and tumor uptake50
A novel bidirectional perfusion-like administered system for NIR-II fluorescence imaging precision diagnosis of bladder cancer45
Diethyldithiocarbamate copper nanoparticle overcomes resistance in cancer therapy without inhibiting P-glycoprotein42
Macrophage membrane modified baicalin liposomes improve brain targeting for alleviating cerebral ischemia reperfusion injury40
Peroxidase modification-driven silymarin liposomes for the treatment of liver fibrosis37
Novel combination of bioactive agents in bilayered dermal patches provides superior wound healing36
Engineered photonic near-infrared light activated photothermal theranostic nanovaccine induced targeted remodeling of tumor microenvironment36
Rational design of nanotherapy for ulcerative colitis: New strategies, mechanistic approaches, and translational challenges34
Determination of spectroscopy marker of atherosclerotic carotid stenosis using FTIR-ATR combined with machine learning and chemometrics analyses32
In vitro assessment of nanomedicines' propensity to cause palmar-plantar erythrodysesthesia: A Doxil vs. doxorubicin case study30
Coatsome-replicon vehicles: Self-replicating RNA vaccines against infectious diseases28
Targeting prostate cancer with Clostridium perfringens enterotoxin functionalized nanoparticles co-encapsulating imaging cargo enhances magnetic resonance imaging specificity27
Exploiting the preferential phagocytic uptake of nanoparticle-antigen conjugates for the effective treatment of autoimmunity27
Chitosan-covered calcium phosphate particles as a drug vehicle for delivery to the eye25
Poly(lipoic acid)-based nanoparticles as a new therapeutic tool for delivering active molecules25
Electrospun electroconductive constructs of aligned fibers for cardiac tissue engineering24
Intrinsic variability of fluorescence calibrators impacts the assignment of MESF or ERF values to nanoparticles and extracellular vesicles by flow cytometry24
Cerium oxide nanoparticle conjugation to microRNA-146a mechanism of correction for impaired diabetic wound healing24
Potential nanotechnology-based diagnostic and therapeutic approaches for Meniere's disease24
0.49181008338928